Multi Gene Vascular Systems Ltd. (MGVS), which is developing treatments for heart and arterial diseases based on stem cell technology, will receive a $2 million owners loan. The company obtained a similar owners' loan earlier this year.

MGVS was founded by CEO Guy Yachin, and president and CTO Dr. Moshe Flugelman. The company has raised $10 million to date, including from Tamir Fishman Venture Capital (TASE: TFVC), Ofer Holdings Group unit Ofer Hi Tech Ltd., and Eitan Wertheimer. It has also obtained funding from the Office of the Chief Scientist.